The long noncoding RNA, H19, has been shown to be markedly overexpressed in individuals with NEPC, and studies have confirmed that H19 not only triggers differentiation of PCa into NEPC but also bolsters resistance of tumor cells to ADT. This evidence concerns the gene H19 and neoplasm.